Skip to main content
OpenTrials
Completed

NCT Number: NCT04891549

Tension Band Versus Locking Plate Fixation for the Treatment of Patella Fractures

This study is a multicenter pragmatic, prospective, assessor-blinded, randomized independent clinical trial in which we compare locking plate fixation to standard tension band fixation in patients with patella fractures.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aalborg University Hospital, Aalborg, Denmark

Loading trial locations.

About this study

This study is a multicenter pragmatic, prospective, assessor-blinded, randomized independent clinical trial in which we compare locking plate fixation to standard tension band fixation in patients with patella fractures.

Primary objective The overall objective of the study is to compare the 1-year patient-reported Knee Injury and Osteoarthritis Outcome Score (KOOS5) after standard tension band fixation with locking plat fixation for patients with patella fractures.

Secondary objectives Several other analyses are of interest and are planned but are not objectives of this study. Therefore, these analyses will, for the major part, hypothesis-generating. Analyses of this type include, but are not limited to harms, muscle atrophy, pain, general health, gait function, time to return to work and economical consequences between the two groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Above 18 years of age
  • Patella fracture suitable for surgically treatment, with both surgical methods
  • AO classification 34-B, 34-C

Exclusion criteria

  • Open patella fracture above Gustillo grade 2
  • Bilateral patella fracture
  • Total knee replacement in the affected extremity
  • Other fractures of the affected extremity within the previous 12 months.
  • Other reasons for exclusion (unable to understand Danish, mentally unable to participate, etc).
  • Prior ipsilateral patella fracture

Treatment and study plan

Tension band fixation

Procedure

Fracture fixation of the patella fracture with tension band.

Plate fixation

Procedure

Fracture fixation of the patella fracture with a plate.

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score - (KOOS5)

    Time frame: One year following treatment

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS 5 subscales.

Secondary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score - (KOOS5)

    Time frame: 3- and 6 months

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

  2. Knee Injury and Osteoarthritis Outcome Score - subscales: pain, ADL, symptoms, sport and QOL.

    Time frame: 3-, 6- and 12-months

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) 29 is a standardised patient-reported questionnaire developed to evaluate knee problems. The questionnaire includes five subscales: pain, ADL, symptoms, sport and QOL and an overall score KOOS5 can be calculated. A total score of 100 indicates no symptoms, and 0 indicates major symptoms.

  3. EQ-5D-5L questionnaire (5-level version)

    Time frame: 3-, 6- and 12-months

    General health will be assessed using EQ-5D-5L questionnaire (5-level version), both the descriptive index and the EQ-VAS. It consists of five dimensions: Mobility, self-care, usual activities, pain/discomfort and anxiety/depression, and a self-rated health scale on a 20 cm vertical, visual analogue scale with endpoints labelled 'the best health you can imagine' and 'the worst health you can imagine'. An Eq5d-5L index of 1.0 indicated full health, 0 death, and -0.59 denoted a condition worse than death.

  4. Pain intensity measured on a 10 cm VAS scale

    Time frame: 3-, 6- and 12-months

    Development in pain will be recorded by patient-reported pain intensity measured on a 10 cm visual analogue scale (VAS) with endpoints "no pain" and "maximal pain" for the worst pain during the last 24 hours and resting pain.

  5. "PainDETECT" questionnaire

    Time frame: 3-, 6- and 12-months

    Knee pain and neuropathic pain will be assessed using the "PainDETECT" questionnaire. The "PainDETECT" screening questionnaire uses a scoring method between 1-38. A total score of 1 indicates no symptoms, and 38 indicates major symptoms.

  6. Bone union

    Time frame: 3-, 6- and 12-months

    Bone union, will be evaluated on standard AP and side X-rays of the fractured patella. The evaluation of bone union will be defined as: i) visible callus formation, diminished no visible fracture line and no pain from the fracture site at weight-bearing and at clinical examination.

  7. Maximum isometric knee-extension strength

    Time frame: 12-months

    Maximum isometric knee-extension strength at 60 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)

  8. Maximum isometric knee-flexion strength

    Time frame: 12-months

    Maximum isometric knee-flexion strength at 90 degrees knee flexion measured as Nm/kg body mass. Will be measured bilaterally by a strap-mounted dynamometer attached to the wall (Mecmesin AFG2500, Mecmesin Ltd, West Sussex, UK)

  9. Knee range of motion

    Time frame: 3-, 6- and 12-months

    Knee range of motion. With the patient supine on an examination table the full range of passive motion in both knee joints will be measured using a standard goniometer.

  10. Time to return to work

    Time frame: 3-, 6- and 12-months

    Measure the time from surgery to end of sick leave measured in days

Other outcomes

  1. Harms

    Time frame: 3-, 6- and 12-months

    Adverse events, defined as any negative or unwanted reactions to the two groups will be recorded. Based on previous reports we will focus on: infection, DVT and re-operation. Patients are continuously requested to report any suspicion of a potential AE. Furthermore, adverse events (AE) will be recorded at 3-, 6- and 12-months follow-up by asking patients about potential AEs using open-probe questioning to ensure that all AEs are recorded. Furthermore, medical records will be checked at the primary endpoint (12 months) for all AEs occurring from inclusion until the 12 months follow-up. An AE is defined as any undesirable experience during follow-up leading to contact with the healthcare system (general practitioner or hospital). If an AE result in hospitalization, prolonged inpatient hospital care, result in re-surgery, or if an AE is life-threatening, result in death, permanent disability or damage, they will be categorized as serious adverse events (SAEs).

Sponsors and collaborators

Lead sponsor

Rasmus Elsøe

Other

Collaborators

  • Aarhus University Hospital
  • Randers Regional Hospital
  • Regional Hospital Hjoerring
  • Regional Hospital Kolding
  • Viborg Regional Hospital

Registry information

Official study title

TENSION BAND VERSUS LOCKING PLATE FIXATION FOR THE TREATMENT OF PATELLA FRACTURE - a High Quality, Multicenter, Randomized Clinical Trial

Acronym: TENPLA

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
May 18, 2021
Registry last updated
Jan 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.